These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17975142)

  • 1. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.
    Geerts D; Wallick CJ; Koomoa DL; Koster J; Versteeg R; Go RC; Bachmann AS
    Clin Cancer Res; 2007 Nov; 13(21):6312-9. PubMed ID: 17975142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles.
    Koomoa DL; Go RC; Wester K; Bachmann AS
    Neurosci Lett; 2008 May; 436(2):171-6. PubMed ID: 18395978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration.
    Borsics T; Lundberg E; Geerts D; Koomoa DL; Koster J; Wester K; Bachmann AS
    Cancer Sci; 2010 Jul; 101(7):1624-31. PubMed ID: 20412121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
    Yco LP; Geerts D; Koster J; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2).
    Fo CS; Coleman CS; Wallick CJ; Vine AL; Bachmann AS
    Gene; 2006 Apr; 371(1):154-65. PubMed ID: 16481131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
    Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
    Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
    Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
    Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
    Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
    Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
    Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
    Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
    De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
    Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
    Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
    Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
    Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
    Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
    Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
    Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.